U.S. markets closed

Ocular Therapeutix: 1Q Earnings Snapshot

BEDFORD, Mass. (AP) _ Ocular Therapeutix Inc. (OCUL) on Friday reported a loss of $17.1 million in its first quarter.

The Bedford, Massachusetts-based company said it had a loss of 45 cents per share.

The biotechnology company posted revenue of $492,000 in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $446,000.

The company's shares closed at $3.66. A year ago, they were trading at $6.73.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL